Search Results 41-50 of 16460 for Proto-oncogene
... proto-oncogene (RET) rearrangement/fusion, or one not listed following approval by the study chair prior to registration. Patients must have measurable ...
Oncogenic Ect2 signaling in cancer. Epithelial cell transforming sequence 2 (Ect2) is a guanine nucleotide exchange factor that activates the Rho family of ...
Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation analyses to assure that the derived models ...
The lab team has confirmed activation of this signaling pathway by oncogenic KRas as a key event driving the development of pancreatic cancer. The lab's ...
Learn about this newer form of radiation therapy, used to treat cancer and noncancerous tumors, and how it's different from X-ray radiation.
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the ...
John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.